Skip to main content
GutCited

Fructooligosaccharides (FOS) لـ Chronic Constipation

C

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dconstipation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

الخلاصة

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

Key Study Findings

Review
Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.
Dose: None مقابل: None Outcome: gut health outcomes including microbiota modulation and SCFA … التأثير: None None

المجتمع المدروس: healthy individuals, children, elderly, and those with constipation, metabolic syndrome, or dysbiosis

Randomized Controlled Trial n=67 4 weeks Double-blind
Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with …
Dose: None مقابل: Placebo Outcome: Weekly spontaneous bowel movements التأثير: 4.94 vs 3.00 (P<0.001) P<0.001

المجتمع المدروس: Older adults >=60 with functional constipation (Rome IV)

Other
Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned …
Dose: 2 g مقابل: None Outcome: Constipation symptoms التأثير: None P < 0.05

المجتمع المدروس: Constipation patients

Randomized Controlled Trial Double-blind
Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium.
Dose: 6 g مقابل: Placebo Outcome: Constipation symptoms التأثير: None None

المجتمع المدروس: Constipation patients

Systematic Review
Fructooligosaccharides for Relieving Functional Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Dose: None مقابل: None Outcome: Constipation symptoms التأثير: OR: 10.36 p < 0.00001

المجتمع المدروس: Constipation patients

Randomized Controlled Trial Double-blind
Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics.
Dose: None مقابل: Placebo Outcome: Constipation symptoms التأثير: None None

المجتمع المدروس: Constipation patients

Key Statistics

4

الدراسات

350

المشاركون

Positive

C

التقييم

Referenced Papers

Journal of Parkinson's … 2024 4 اقتباسات
Carbohydrate polymers 2022 77 اقتباسات
Journal of physiology … 2009 312 اقتباسات
Journal of the … 2007 84 اقتباسات
BioFactors (Oxford, England) 2004 48 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
2-10 g/day
prebioticeffect:
5-8 g/day for bifidogenic effect
constipationsupport:
5-10 g/day

الحد الأعلى: Well-tolerated up to 20 g/day; start low to avoid excess gas

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Positive --
None 4 weeks Positive 67
2 g -- Neutral --
6 g -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --

أفضل وقت للتناول: With meals; divide doses throughout the day

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
  • Abdominal cramping at higher doses
  • May worsen IBS symptoms in FODMAP-sensitive individuals
  • Loose stools at excessive doses

التفاعلات المعروفة

  • Other FODMAPs (cumulative fermentation effect in sensitive individuals)
  • Blood sugar-lowering medications (FOS may modestly affect glycemic response)
  • Calcium supplements (FOS may enhance calcium absorption)

الحد الأقصى المسموح به: Well-tolerated up to 20 g/day; start low to avoid excess gas

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Chronic Constipation?
Based on 4 studies with 350 participants, there is limited but promising evidence that Fructooligosaccharides (FOS) may support Chronic Constipation management. Our evidence grade is C (Some Evidence).
How much Fructooligosaccharides (FOS) should I take for Chronic Constipation?
Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Fructooligosaccharides (FOS)?
Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Fructooligosaccharides (FOS) and Chronic Constipation?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Related Evidence

مكونات أخرى لـ Chronic Constipation

Fructooligosaccharides (FOS) لحالات أخرى

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.